Tyner, Jeffrey W.
Tognon, Cristina E.
Bottomly, Daniel
Wilmot, Beth
Kurtz, Stephen E.
Savage, Samantha L.
Long, Nicola
Schultz, Anna Reister
Traer, Elie
Abel, Melissa
Agarwal, Anupriya
Blucher, Aurora
Borate, Uma
Bryant, Jade
Burke, Russell
Carlos, Amy
Carpenter, Richie
Carroll, Joseph
Chang, Bill H.
Coblentz, Cody
d’Almeida, Amanda
Cook, Rachel
Danilov, Alexey
Dao, Kim-Hien T.
Degnin, Michie
Devine, Deirdre
Dibb, James
Edwards, David K. V
Eide, Christopher A.
English, Isabel
Glover, Jason
Henson, Rachel
Ho, Hibery
Jemal, Abdusebur
Johnson, Kara
Johnson, Ryan
Junio, Brian
Kaempf, Andy
Leonard, Jessica
Lin, Chenwei
Liu, Selina Qiuying
Lo, Pierrette
Loriaux, Marc M.
Luty, Samuel
Macey, Tara
MacManiman, Jason
Martinez, Jacqueline
Mori, Motomi
Nelson, Dylan
Nichols, Ceilidh
Peters, Jill
Ramsdill, Justin
Rofelty, Angela
Schuff, Robert
Searles, Robert
Segerdell, Erik
Smith, Rebecca L.
Spurgeon, Stephen E.
Sweeney, Tyler
Thapa, Aashis
Visser, Corinne
Wagner, Jake
Watanabe-Smith, Kevin
Werth, Kristen
Wolf, Joelle
White, Libbey
Yates, Amy
Zhang, Haijiao
Cogle, Christopher R.
Collins, Robert H.
Connolly, Denise C.
Deininger, Michael W.
Drusbosky, Leylah
Hourigan, Christopher S.
Jordan, Craig T.
Kropf, Patricia
Lin, Tara L.
Martinez, Micaela E.
Medeiros, Bruno C.
Pallapati, Rachel R.
Pollyea, Daniel A.
Swords, Ronan T.
Watts, Justin M.
Weir, Scott J.
Wiest, David L.
Winters, Ryan M.
McWeeney, Shannon K.
Druker, Brian J.
Article History
Received: 4 April 2018
Accepted: 14 August 2018
First Online: 17 October 2018
Competing interests
: J.W.T. receives research support from Agios, Aptose, Array, AstraZeneca, Constellation, Genentech, Gilead, Incyte, Janssen, Seattle Genetics, Syros and Takeda, and is a co-founder of Vivid Biosciences. M.W.D. serves on the advisory boards of and/or as a consultant for Novartis, Incyte and BMS, and receives research funding from BMS and Gilead. C.S.H. receives research funding from Merck. T.L.L. consults for Jazz Pharmaceuticals and receives research funding from Tolero, Gilead, Precient, Ono, Bio-Path, Mateon, Genentech/Roche, Trovagene, Abbvie, Pfizer, Celgene, Imago, Astellas, Karyopharm, Seattle Genetics and Incyte. D.A.P. receives research funding from Pfizer and Agios and served on the advisory boards of Pfizer, Celyad, Agios, Celgene, AbbVie, Argenx, Takeda and Servier. B.J.D. serves on the advisory boards of Gilead, Aptose, and Blueprint Medicines and is a principal investigator or coinvestigator on Novartis and BMS clinical trials. The Oregon Health & Science University (on behalf of B.J.D.) has contracts with these companies to pay for patient costs, nurse and data manager salaries and institutional overhead. B.J.D. does not derive salary, nor does his laboratory receive funds from these contracts. The authors certify that all compounds tested in this study were chosen without input from any of the industry partners.